• 656 Citations
  • 10 h-Index
19972019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

My research is focused on enhancing therapeutic efficacy in cancer. I have collaborated with Dr. Andras Lacko on the development of a lipoprotein-based targeted drug delivery vehicle for cancer chemotherapeutic agents. Also, I collaborate with Dr. Riyaz Basha in investigating the strategies to induce therapeutic efficacy of the chemotherapeutic agents used in standard care. We are investigating the effect of combination therapy of standard chemotherapeutic agents with clotum and Mithramicin for Ewing sarcoma, medulloblastoma, and neuroblastoma cell lines.

Education/Academic qualification

MS in Applied Chemistry, Cochin University of Science and Technology

BS in Chemistry, University of Kerala

PhD in Chemistry, University of Kerala

Fingerprint Dive into the research topics where Maya Nair is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 656 Citations
  • 10 h-Index
  • 20 Article
  • 2 Review article
Open Access
  • 3 Scopus citations

    Defining early life stress as a precursor for autoimmune disease

    Choe, J. Y., Nair, M., Basha, R., Kim, B. J. & Jones, H. P., 1 Jan 2019, In : Critical Reviews in Immunology. 39, 5, p. 329-342 14 p.

    Research output: Contribution to journalArticle

  • Ovarian cancer: Current status and strategies for improving therapeutic outcomes

    Chandra, A., Pius, C., Nabeel, M., Nair, M., Vishwanatha, J. K., Ahmad, S. & Basha, R., 1 Nov 2019, In : Cancer Medicine. 8, 16, p. 7018-7031 14 p.

    Research output: Contribution to journalReview article

    Open Access
  • 6 Scopus citations

    Pancreatic cancer: An emphasis on current perspectives in immunotherapy

    Patel, K., Siraj, S., Smith, C., Nair, M., Vishwanatha, J. K. & Basha, R., 1 Jan 2019, In : Critical Reviews in Oncogenesis. 24, 2, p. 105-118 14 p.

    Research output: Contribution to journalArticle

  • Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles

    Sabnis, N., Nair, M., Israel, M., McConathy, W. J. & Lacko, A. G., 5 Dec 2012, In : International Journal of Nanomedicine. 7, p. 975-983 9 p.

    Research output: Contribution to journalArticle

  • 41 Scopus citations